| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |